Literature DB >> 16750604

Development of manufacturing method for rapidly disintegrating oral tablets using the crystalline transition of amorphous sucrose.

Masaaki Sugimoto1, Shinji Narisawa, Koji Matsubara, Hiroyuki Yoshino, Minoru Nakano, Tetsurou Handa.   

Abstract

The industrial manufacturing of rapidly disintegrating oral tablets with a sufficient tensile strength was investigated. The manufacturing method of the tablets involved the crystalline transition of amorphous sucrose that was produced in the process of fluidized bed granulation of mannitol using sucrose solution as a binder. The aim of this article was to clarify the usefulness of amorphous sucrose formed during the granulation for the rapidly disintegrating oral tablets manufacturing, and to investigate the effects of crystalline transition of the amorphous sucrose in granules on the characteristics of the resultant tablets prepared by this crystalline transition (CT) method. The X-ray diffraction measurement and thermal analysis showed that amorphous sucrose was effectively formed in granules consisting of 95% mannitol and 5% sucrose when the granulation was performed on the condition of water content of 4%. The tensile strength of tablets comprised of the granules, which were compressed before the crystallization of amorphous sucrose, increased remarkably after storage, because new internal solid bridges were formed in the tablets as a result of the crystallization. We conclude that rapidly disintegrating oral tablets can effectively be manufactured by the CT method using the granules obtained by the fluidized bed granulation method.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16750604     DOI: 10.1016/j.ijpharm.2006.04.004

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

Review 1.  Additive Manufacturing of Solid Products for Oral Drug Delivery Using Binder Jetting Three-Dimensional Printing.

Authors:  Yingya Wang; Anette Müllertz; Jukka Rantanen
Journal:  AAPS PharmSciTech       Date:  2022-07-14       Impact factor: 4.026

Review 2.  Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives.

Authors:  Mohammadali Poursharifi Ghourichay; Seyed Hossein Kiaie; Ali Nokhodchi; Yousef Javadzadeh
Journal:  Biomed Res Int       Date:  2021-12-24       Impact factor: 3.411

3.  Development and evaluation of fixed dose bi therapy sublingual tablets for treatment stress hypertension and anxiety.

Authors:  Mohamed A El-Nabarawi; Saadia A Tayel; Nadia A Soliman; Hadel A Abo Enin
Journal:  J Pharm Bioallied Sci       Date:  2013-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.